Immuno-modification of enhancing stem cells targeting for myocardial repair

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 7, 2015, Pages 1483-1491

  Yu, Jiashing ^a   Wu, Yuan Kun ^a   Gu, Yiping ^b,c   Fang, Qizhi ^b   Sievers, Richard ^b   Ding, Chun Hua ^b   Olgin, Jeffrey E ^b   Lee, Randall J ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody targeting; Electrophysiology; Myocardial infarction; Stem cells

Indexed keywords

BISPECIFIC ANTIBODY; CD34 ANTIBODY; CD34 ANTIGEN; PROTEIN BINDING;

ACTION POTENTIAL DURATION; ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FIBROSIS; FLOW CYTOMETRY; HEART CONDUCTION; HEART DILATATION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINUS NODE CONDUCTION VELOCITY; STEM CELL; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; ECHOGRAPHY; HEART FUNCTION TEST; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; IMMUNOLOGY; INJECTION; KINETICS; METABOLISM; MYOCARDIAL INFARCTION; NUDE RAT; PATHOLOGY; PATHOPHYSIOLOGY; REFRACTORY PERIOD; STEM CELL TRANSPLANTATION;

RATTUS; RODENTIA;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGENS, CD34; FEMALE; HEART CONDUCTION SYSTEM; HEART FUNCTION TESTS; HUMANS; INJECTIONS; KINETICS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; RATS, NUDE; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; STEM CELL TRANSPLANTATION; STEM CELLS; TACHYCARDIA, VENTRICULAR; ULTRASONOGRAPHY;

EID: 84933279165     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12439     Document Type: Article

References (25)

1. + hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol. 2008; 104: 1793-800.
2. Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther. 2011; 22: 3-17.
3. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428: 664-8.
4. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428: 668-73.
5. Schachinger V, Erbs S, Elsasser A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006; 27: 2775-83.
6. Zohlnhofer D, Dibra A, Koppara T, et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol. 2008; 51: 1429-37.
7. Dawn B, Tiwari S, Kucia MJ, et al. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells. 2008; 26: 1646-55.
8. Engelmann MG, Theiss HD, Hennig-Theiss C, et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2006; 48: 1712-21.
9. Vanderheyden M, Vercauteren S, Mansour S, et al. Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant. 2007; 16: 919-25.
10. Henning RJ, Burgos JD, Vasko M, et al. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplant. 2007; 16: 907-17.
11. Mihardja SS, Gao D, Sievers RE, et al. Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction. PLoS ONE. 2010; 5: e10384.
12. Huang NF, Sievers RE, Park JS, et al. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc. 2006; 1: 1596-609.
13. Wolf CM, Moskowitz IP, Arno S, et al. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc Natl Acad Sci USA. 2005; 102: 18123-8.
14. Masseroli M, Caballero T, O'Valle F, et al. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol. 2000; 32: 453-64.
15. Daunoravicius D, Besusparis J, Zurauskas E, et al. Quantification of myocardial fibrosis by digital image analysis and interactive stereology. Diagn Pathol. 2014; 9: 114.
16. Yu J, Gu Y, Du KT, et al. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials. 2009; 30: 751-6.
17. Christman KL, Fok HH, Sievers RE, et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004; 10: 403-9.
18. Lee RJ, Fang Q, Davol PA, et al. Antibody targeting of stem cells to infarcted myocardium. Stem Cells. 2007; 25: 712-7.
19. Springer ML, Sievers RE, Viswanathan MN, et al. Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol. 2005; 289: H1307-14.
20. Everett THT, Verheule S, Wilson EE, et al. Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium. Am J Physiol Heart Circ Physiol. 2004; 286: H2452-60.
21. Bayly PV, KenKnight BH, Rogers JM, et al. Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans Biomed Eng. 1998; 45: 563-71.
22. Verheule S, Wilson E, Banthia S, et al. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am J Physiol Heart Circ Physiol. 2004; 287: H634-44.
23. Gherghiceanu M, Manole CG, Popescu LM. Telocytes in endocardium: electron microscope evidence. J Cell Mol Med. 2010; 14: 2330-4.
24. Zhao B, Liao Z, Chen S, et al. Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. J Cell Mol Med. 2014; 18: 780-9.
25. Joung B, Kim IK, Lee MH, et al. Bone marrow mononuclear stem cells transplanted in rat infarct myocardium improved the electrical conduction without evidence of proarrhythmic effects. Yonsei Med J. 2007; 48: 754-64.